Table of Contents
-
1.1 Product Overview and Scope of Product
1.2 Global Market of Urological Cancer Therapeutics Drugs
-
2.1 Market Revenue by Product Types:
-
2.1.1 Table Market Revenue (in million USD) by Product Types (Historic Data)
2.1.2 Graph Market Revenue ( in million USD) by Product Types (Current & Forecast Data)
2.1.3 Graph Market Share (%) by Product Types in 2025
-
2.2.1 Table Market Volume (in million Units) by Product Types (Historic Data)
2.2.2 Graph Market Volume ( in million Units) by Product Types (Current & Forecast Data)
2.2.3 Graph Market Share (%) by Product Types in 2025
-
2.3.1 Graph Global Xofigo (radium Ra 223 dichloride) Revenue (in million USD ) ()
2.3.2 Graph Global Xofigo (radium Ra 223 dichloride) Volume (in million units ) ()
2.3.3 Table Xofigo (radium Ra 223 dichloride) Geographical Analysis
-
2.4.1 Graph Jevtana (cabazitaxel) Revenue (in million USD) ()
2.4.2 Graph Global Jevtana (cabazitaxel) Volume (in million Units ) ()
2.4.3 Table Jevtana (cabazitaxel) Geographical Analysis
2.5 Inlyta (axitinib)
-
2.5.1 Graph Inlyta (axitinib) Revenue (in million USD) ()
2.5.2 Graph Global Inlyta (axitinib) Volume (in million Units ) ()
2.5.3 Table Inlyta (axitinib) Geographical Analysis
2.6 Votrient (pazopanib hydrochloride)
-
2.6.1 Graph Votrient (pazopanib hydrochloride) Revenue (in million USD) ()
2.6.2 Graph Global Votrient (pazopanib hydrochloride) Volume (in million Units ) ()
2.6.3 Table Votrient (pazopanib hydrochloride) Geographical Analysis
2.7 Sutent (sunitinib malate)
-
2.7 .1 Graph Sutent (sunitinib malate) Revenue (in million USD) ()
2.7.2 Graph Global Sutent (sunitinib malate) Volume (in million Units ) ()
2.7.3 Table Sutent (sunitinib malate) Geographical Analysis
2.8 Xtandi (enzalutamide)
-
2.8 .1 Graph Xtandi (enzalutamide) Revenue (in million USD) ()
2.8.2 Graph Global Xtandi (enzalutamide) Volume (in million Units ) ()
2.8.3 Table Xtandi (enzalutamide) Geographical Analysis
2.9 Opdivo (nivolumab)
-
2.9 .1 Graph Opdivo (nivolumab) Revenue (in million USD) ()
2.9.2 Graph Global Opdivo (nivolumab) Volume (in million Units ) ()
2.9.3 Table Opdivo (nivolumab) Geographical Analysis
2.10 Provenge (sipuleucel-T)
-
2.10 .1 Graph Provenge (sipuleucel-T) Revenue (in million USD) ()
2.10.2 Graph Global Provenge (sipuleucel-T) Volume (in million Units ) ()
2.10.3 Table Provenge (sipuleucel-T) Geographical Analysis
-
• Hospital
• Medical Research Laboratory
3.1 Table Market Revenue (in million USD) by Application (Historic Data) 3.2 Table Market Revenue (in million USD) by Application (Current & Forecast Data) 3.3 Hospital
-
3.3.1 Graph Global Hospital Revenue (in million USD ) ()
3.3.2 Table Global Hospital Geographical Analysis
-
3.4.1 Graph Global MEDICAL RESEARCH LABORATORY Revenue (in million USD ) ()
3.4.2 Table Global MEDICAL RESEARCH LABORATORY Geographical Analysis
-
• Global Market Revenue (In Million) and Growth Rate Comparison by Regions (2018-2026)
4.1. North America Urological Cancer Therapeutics Drugs Market Report Analysis()
-
4.1.1 USA
4.1.2 Canada
4.1.3 Mexico
-
4.2.1 UK
4.2.2 Germany
4.2.3 France
4.2.4 Italy
4.2.5 Rest Of Europe
-
4.3.1 China
4.3.2 Japan
4.3.3 India
4.3.4 Singapore
4.3.5 Malaysia
4.3.6 Rest Of APAC
-
4.4.1 Africa
4.4.2 Middle East
4.4.3 South America
-
5.1 Novartis
-
5.1.1 Overview :
5.1.2 Basic Company Information:
5.1.3 Financial Overview
5.1.3 Production Overview
5.1.4 Geography Revenue Mix ( 2018)
5.1.5Business Revenue Mix
5.1.6 Recent Development
-
5.2.1 Overview :
5.2.2 Basic Company Information:
5.2.3 Financial Overview
5.2.4 Production Overview
5.2.5 Geography Revenue Mix ( 2018)
5.2.6 Business Revenue Mix
5.2.7 Recent Development
-
5.3.1 Overview :
5.3.2 Basic Company Information:
5.3.3 Financial Overview
5.3.4 Production Overview
5.3.5 Geography Revenue Mix ( 2018)
5.3.6 Business Revenue Mix
5.3.7 Recent Development
-
5.4.1 Overview :
5.4.2 Basic Company Information:
5.4.3 Financial Overview
5.4.4 Production Overview
5.4.5 Geography Revenue Mix ( 2018)
5.4.6 Business Revenue Mix
5.4.7 Recent Development
-
6.1 Research Finding:
6.2 Conclusion:
-
7.1 Methodology/Research Approach
7.2 Research Programs/Design
7.3 Market Size Estimation
7.4 Market Breakdown and Data Triangulation
7.5 Data Source
7.5.1 Secondary Sources
7.5.2 Primary Sources
7.6 Disclaimer